Moxibustion Treatment, Alongside Conventional Western and Chinese Herbal Medical Therapies, May Improve Survival in Stage-IV Pulmonary Adenocarcinomas in a Dosage-Dependent Manner: A Prospective Observational Study With Propensity Score Analysis

Background: 25% to 30% of primary stage IV pulmonary adenocarcinomas (PUAD-IV) die within 3 months. Many ≥3 months survivors at long follow-up are alive with disease (AWD). Platinum-based chemotherapy (PBC), tyrosine kinase inhibitors- targeted therapy (TKI-TT), and Chinese herbal medicines (oral CH...

詳細記述

書誌詳細

主要な著者:	Hegen Li MD, Veronika Lindberg MSc, Lihua Zhu MD, PhD, Xiange Huang MD, Jiali Feng MD, Jan P. A. Baak MD, PhD, FICP, FRCPath, FIAC, DrHC(Antwerp), MScTCM
フォーマット:	Artigo
言語:	Inglês
出版事項:	SAGE Publishing 2025-06-01
シリーズ:	Integrative Cancer Therapies
オンライン･アクセス:	https://doi.org/10.1177/15347354251342739
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!